NMR

Bruker Introduces Novel NMR Scientific Capabilities for Structural Biology Discoveries in Membrane Proteins and Protein Aggregates

Retrieved on: 
Monday, April 8, 2024
Research, Technology, Semiconductor, Genetics, Health Technology, Nanotechnology, Biotechnology, Hardware, Health, Science, CNRS, CPMAS, 2000s, HCN, Membrane, Corporation, DNP, NMR, Bruker, Hertz, Protein, Multimedia, MAS, BRKR, WB, Medical imaging

Bruker Corporation (Nasdaq: BRKR), the leading provider of nuclear magnetic resonance (NMR) spectroscopy solutions, announces the introduction of novel high-resolution solid-state NMR scientific capabilities that can enable unprecedented structural biology discoveries in large proteins, membrane proteins and in protein aggregates.

Key Points: 
  • Bruker Corporation (Nasdaq: BRKR), the leading provider of nuclear magnetic resonance (NMR) spectroscopy solutions, announces the introduction of novel high-resolution solid-state NMR scientific capabilities that can enable unprecedented structural biology discoveries in large proteins, membrane proteins and in protein aggregates.
  • Featuring a 160 kHz Magic Angle Spinning (MAS) system, it takes high-resolution MAS and proton detection on solid biological samples to the next level, enabling new scientific discoveries.
  • The dramatically enhanced 1H-NMR resolution and enhanced T2' times make 160 kHz MAS suitable for the study of large proteins, membrane proteins and protein aggregates.
  • In addition, a 160 kHz MAS probe is now installed on the 1.0 GHz NMR at CNRS Lyon, where it expands the scientific capabilities of biological solid-state research.

Bruker Advances Magnet Technology for Broader Adoption of NMR in Academic and Biopharma Research, and Process Analytical Technologies

Retrieved on: 
Monday, April 8, 2024
Biotechnology, Technology, Professional Services, Health, Pharmaceutical, Semiconductor, Research, Data Analytics, Software, Science, Hardware, Quality control, Evo, Corporation, NMR, Active ingredient, Bruker, AI, Ascend, PAT, API, Safety, Magnet, Hertz, Machine learning, Multimedia, Fourier, BRKR, Medical imaging

Bruker Corporation (Nasdaq: BRKR), the leading provider of nuclear magnetic resonance (NMR) systems, today announces novel magnet technology and analytical solutions to support broad adoption of NMR in academic basic and clinical research, as well as in biopharma drug discovery, development and process analytical technologies (PAT).

Key Points: 
  • Bruker Corporation (Nasdaq: BRKR), the leading provider of nuclear magnetic resonance (NMR) systems, today announces novel magnet technology and analytical solutions to support broad adoption of NMR in academic basic and clinical research, as well as in biopharma drug discovery, development and process analytical technologies (PAT).
  • The new Ascend Evo 600 magnet is easier to site, has reduced installation and operational costs, and has lower Helium consumption compared to previous 600 MHz magnets.
  • In addition, Bruker expands the applications of its Fourier 80 platform, a benchtop 80 MHz Fourier Transform NMR with a high-performance permanent magnet that requires no cryogens or power.
  • Here, the Fourier 80 system gathers reaction data for AI machine learning to formulate the rules and actions to guide process optimization.

Bluefors Launches Helium Recovery Solution for Single Unit NMR Systems

Retrieved on: 
Monday, April 8, 2024
Nuclear magnetic resonance, NMR, Organization, Helium, Industrial gas

HELSINKI, Finland, April 8, 2024 /PRNewswire/ -- Bluefors today announced the Cryomech HeRL02-RM – a new Helium Reliquefier designed specifically for helium recovery from a single Nuclear Magnetic Resonance (NMR) unit.

Key Points: 
  • HELSINKI, Finland, April 8, 2024 /PRNewswire/ -- Bluefors today announced the Cryomech HeRL02-RM – a new Helium Reliquefier designed specifically for helium recovery from a single Nuclear Magnetic Resonance (NMR) unit.
  • Helium Reliquefiers help to conserve the use of valuable helium, safeguarding users against helium supply issues and protecting against helium price fluctuations.
  • "The HeRL02-RM is an ideal solution for small laboratories with one to three NMR systems, and organizations with dispersed magnets.
  • For facilities with greater helium boil off, Bluefors continues to offer full scale helium recovery solutions.

Nanalysis Corp. Receives Funding Supporting AI Software Development for Detection of Illicit Substances

Retrieved on: 
Thursday, April 4, 2024
Nuclear magnetic resonance, Prohibition, Culture, NSCI, Substance abuse, MRI, Artificiality, NRC, AB, NMR, Research, FRA, Plasma protein binding, LKA, AI, NPS, Laboratory, Nanalysis, OTCQX, National Research Council, Artificial intelligence, Medical imaging

This characterization requires an array of different analytical techniques and is carried out by skilled forensic scientists in thousands of laboratories worldwide.

Key Points: 
  • This characterization requires an array of different analytical techniques and is carried out by skilled forensic scientists in thousands of laboratories worldwide.
  • In many cases these laboratories face significant sample backlog due to volume and may have difficulties in identifying new designer drugs.
  • These tools will not only identify known illicit drugs but will also identify unknown drugs that are derivatives of known illicit substances also referred to as designer drugs or new psychoactive substances (NPS).
  • The company is developing this application in the context of its quantitative NMR platform technology, which has other applications as well, beyond illicit drug detection.

Synthesizing and Decoding Posttranslational Modifications of Disordered Proteins, Upcoming Webinar Hosted by Xtalks

Retrieved on: 
Wednesday, February 7, 2024
Intrinsically disordered proteins, Drug design, TU Wien, Peptide, Knowledge, Institute of technology, Protein, Research, NMR, Fine chemical

TORONTO, Feb. 7, 2024 /PRNewswire-PRWeb/ -- Explore the structural impact of posttranslational modifications, chemical synthesis strategies, and their impact on novel drug design in this informative webinar.

Key Points: 
  • The featured speakers will share strategies for accessing proteins with site-specific posttranslational modifications for structural and biochemical experiments.
  • TORONTO, Feb. 7, 2024 /PRNewswire-PRWeb/ -- Explore the structural impact of posttranslational modifications, chemical synthesis strategies, and their impact on novel drug design in this informative webinar.
  • The impact of posttranslational modifications on protein structure is seldom investigated, leaving a gap in the knowledge of how posttranslational modifications modulate protein function.
  • Furthermore, the impact of posttranslational modifications on protein structure is seldom investigated, leaving a gap in the knowledge of how posttranslational modifications modulate protein function.

Nanalysis Announces Upcoming Webinar and Conference Participation

Retrieved on: 
Wednesday, February 7, 2024
CATSA, OTCQX, Interview, MRI, Research, FRA, AB, Q&A, NSCI, NMR, Medical imaging

CALGARY, AB, Feb. 7, 2024 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company" or "Nanalysis", TSXV: NSCI , OTCQX: NSCIF , FRA: 1N1 ), a leader in portable NMR machines, MRI technology for industrial and research applications, and detection equipment services, announces that Founder and CEO Sane Krakiwsky will be participating in an upcoming webinar and conference.

Key Points: 
  • CALGARY, AB, Feb. 7, 2024 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company" or "Nanalysis", TSXV: NSCI , OTCQX: NSCIF , FRA: 1N1 ), a leader in portable NMR machines, MRI technology for industrial and research applications, and detection equipment services, announces that Founder and CEO Sane Krakiwsky will be participating in an upcoming webinar and conference.
  • The webinar will be a live, interactive online event where attendees are invited to ask the Company questions in real-time following the interview.
  • An archived webcast will be made available for those who cannot join the event live on the day of the webinar.
  • Management will also be available on February 14th and 15th for one-on-one meetings which can be requested through the conference site.

Nanalysis Achieves Record Revenue in Q4

Retrieved on: 
Tuesday, February 6, 2024
Security, OTCQX, Growth, Patent, MRI, Research, United, FRA, AB, NSCI, NMR, Hertz, Software, Airport

CALGARY, AB, Feb. 6, 2024 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company" or "Nanalysis", TSXV: NSCI , OTCQX: NSCIF , FRA: 1N1 ), a leader in portable NMR machines, MRI technology for industrial and research applications, and detection equipment services, provides an estimate of Q4 2023 unaudited revenue and highlights some other recent business accomplishments.

Key Points: 
  • CALGARY, AB, Feb. 6, 2024 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company" or "Nanalysis", TSXV: NSCI , OTCQX: NSCIF , FRA: 1N1 ), a leader in portable NMR machines, MRI technology for industrial and research applications, and detection equipment services, provides an estimate of Q4 2023 unaudited revenue and highlights some other recent business accomplishments.
  • Sean Krakiwsky, Founder and CEO of Nanalysis, states: "We are very pleased with how the fourth quarter closed out 2023, a year not without its challenges.
  • With both Benchtop NMR and Security Services contributing significantly, we were able to achieve fourth quarter unaudited revenues of between $9.3MM and $9.8MM, constituting a new record quarter for Nanalysis.
  • New Quarterly Revenue Record: Q4 2023 revenue will be at least $9.3MM (unaudited), driven by continued expansion of security services related to the Company's airport security maintenance project, as well as continued recovery in Benchtop NMR sales.

Nanalysis Scientific Corp. Provides Update on Security Services Business

Retrieved on: 
Tuesday, January 30, 2024
Research, MRI, Security, AB, Airport, All, CATSA, Workforce, NSCI, OTCQX, FRA, Certification, NMR

Phase-In of Canada-Wide Coverage at All 89 Designated Airports Completed on January 11, 2024

Key Points: 
  • Phase-In of Canada-Wide Coverage at All 89 Designated Airports Completed on January 11, 2024
    CALGARY, AB, Jan. 30, 2024 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company" or "Nanalysis", TSXV: NSCI , OTCQX: NSCIF , FRA: 1N1 ), a leader in portable NMR machines, MRI technology for industrial and research applications, and detection equipment services, gives an update on its subsidiary K'(Prime) Technologies ("KPrime") security services business and the five-year $160 million contract with Canadian Air Transport Security Authority ("CATSA").
  • "Having now taken over all preventative and corrective maintenance services for CATSA, we expect the project to begin generating positive EBITDA in Q1 2024*.
  • This approach will position us to expand the capabilities and opportunities for our Security Services business with other customers and partners."
  • After completion of initial training, the Company expects lower ongoing training costs commensurate with ordinary staff turnover and ongoing certification maintenance.

Flash News: OKX Lists NMR and JOE on its Perpetual Futures Market, Enables Margin Trading and Simple Earn for the Tokens

Retrieved on: 
Thursday, January 11, 2024
Numeraire, Decentralized finance, JOE, API, Token, Investment, UTC, Numerai, OKX, AVAX, Trader Joe's, DEX, NMR, Cryptocurrency

OKX Lists NMR and JOE on its Perpetual Futures Market, Enables Margin Trading and Simple Earn for the Tokens

Key Points: 
  • OKX Lists NMR and JOE on its Perpetual Futures Market, Enables Margin Trading and Simple Earn for the Tokens
    OKX today listed two perpetual swaps: NMR/USDT and JOE/USDT .
  • With these additions, users can trade the NMR and JOE perpetual listings with up to 20x leverage from 8:00 am (UTC) and 10:00 am (UTC) on January 11, respectively.
  • OKX today also enabled margin trading and Simple Earn for NMR and JOE at 7:30 am (UTC) and 9:30 am (UTC), respectively.
  • JOE (JOE) is the native token of Trader Joe , a DEX on the Avalanche (AVAX) blockchain that offers DeFi solutions such as swapping, staking and yield farming.

Global Analytical Standards (GC, MS, LC, IR, NMR, Gravimetry) Market Research Report 2023: Increasing Public-Private Investments in Research to Drive Growth - Forecasts to 2028 - ResearchAndMarkets.com

Retrieved on: 
Friday, December 29, 2023
Retail, Health, Environment, Green Technology, Pharmaceutical, Food, Beverage, Category, Forensic science, Forecasting, NMR, Drug development, Research, Region, Titration, Organic, USD, GC, CRMS, Growth, Chromatography, Fine chemical

The global analytical standards market is projected to reach USD 2.1 billion by 2028 from USD 1.5 billion in 2023, growing at a CAGR of 6.9%

Key Points: 
  • The global analytical standards market is projected to reach USD 2.1 billion by 2028 from USD 1.5 billion in 2023, growing at a CAGR of 6.9%
    This report studies the analytical standards market based on technique, application, methodology, category, and region.
  • Additionally, development of new analytical methods affect the growth of analytical standards market.
  • Based on application, analytical standards is segmented into food & beverages standards, forensic standards, veterinary drug standards, environmental standards, petrochemistry standards and pharmaceutical & life science standards.
  • Organic analytical standards accounted for the largest share of the global analytical standards market in 2022.